SENETEK PLC /ENG/
10-Q, EX-27, 2000-08-11
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: SENETEK PLC /ENG/, 10-Q, 2000-08-11
Next: CARLISLE COMPANIES INC, 10-Q, 2000-08-11



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONSOLIDATED
FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           2,575
<SECURITIES>                                         0
<RECEIVABLES>                                      959
<ALLOWANCES>                                         0
<INVENTORY>                                        472
<CURRENT-ASSETS>                                 4,115
<PP&E>                                           3,945
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  11,605
<CURRENT-LIABILITIES>                            7,659
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         4,719
<OTHER-SE>                                    (10,824)
<TOTAL-LIABILITY-AND-EQUITY>                    11,605
<SALES>                                          1,758
<TOTAL-REVENUES>                                 1,758
<CGS>                                              702
<TOTAL-COSTS>                                      702
<OTHER-EXPENSES>                                 3,207
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,003
<INCOME-PRETAX>                                (3,144)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (3,144)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (3,144)
<EPS-BASIC>                                      (.05)
<EPS-DILUTED>                                    (.05)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission